ArticleScientific reports2021

Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation.

Hurramhon Shokirova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.